Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Pharmacovigilance And Drug Safety Software Market Revenue Growth Supported By A CAGR Of 4.6% Through 2030
A rapid expansion has been observed in the pharmacovigilance and drug safety software market over recent years, with projections indicating a rise from $2.53 billion in 2025 to $2.86 billion in 2026, representing a compound annual growth rate (CAGR) of 12.8%. This historical growth has been driven by several factors, including increased reporting of adverse drug reactions, the global expansion of clinical trials, stricter drug safety regulations, heightened pharmaceutical production, and a growing need for post-marketing surveillance.
Over the coming years, the pharmacovigilance and drug safety software market is anticipated to expand at a significant pace, reaching a valuation of $4.6 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.6%. This projected growth during the forecast period is fueled by several key factors, including the expansion of AI-driven signal detection, the increased development of biologics and specialty drugs, heightened regulatory oversight, a growing trend toward outsourcing pharmacovigilance activities, and an escalating need for real-time safety analytics. Notable trends shaping this period involve a higher uptake of cloud-based pharmacovigilance systems, a stronger emphasis on real-world evidence monitoring, greater automation in the reporting of adverse events, the expansion of integrated drug safety platforms, and an increased demand for compliance-focused safety solutions.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmacovigilance And Drug Safety Software Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing need for personalized medicine is expected to accelerate expansion in the pharmacovigilance and drug safety software market moving forward. Personalized medicine, often referred to as precision medicine, is a healthcare model that customizes treatment plans based on an individual’s genetic, biological, and lifestyle factors. This rise in demand is fueled by better therapeutic outcomes, enhanced capabilities for prevention and early diagnosis, and greater cost efficiency. The pharmacovigilance and drug safety software market facilitates personalized medicine through the incorporation of pharmacogenetics, real-time data analytics, and post-marketing surveillance to improve patient safety, oversee tailored therapies, and reinforce risk management protocols. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, reported that the FDA sanctioned 16 novel personalized therapies for individuals with rare diseases in 2023, up from just 6 approvals in 2022. Consequently, the rising demand for personalized medicine is fueling growth in the pharmacovigilance and drug safety software market.
Pharmacovigilance And Drug Safety Software Market Segment Analysis And Revenue Opportunities
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
Pharmacovigilance And Drug Safety Software Market Trends Reshaping Industry Growth
Key players within the pharmacovigilance and drug safety software market are increasingly concentrating on the creation of advanced technologies, including cloud-based data lake platforms, to bolster adverse event tracking, enhance adherence to regulatory standards, and elevate patient safety during clinical trials and after-market monitoring. Such a cloud-based data lake platform represents a scalable and centralized system capable of storing and analyzing substantial amounts of structured and unstructured safety information in real time, which facilitates sophisticated analytics, artificial intelligence and machine learning modeling, and efficient case management in pharmacovigilance operations. As an example, in December 2023, Thermo Fisher Scientific Inc., a biotechnology firm headquartered in the United States, introduced CorEvidence, a proprietary cloud-based data lake platform aimed at streamlining pharmacovigilance procedures by refining safety data administration and case processing effectiveness, especially for post-authorization safety studies within clinical research registries.
Pharmacovigilance And Drug Safety Software Market Leading Players Shaping Industry Direction
Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel
Access The Complete Pharmacovigilance And Drug Safety Software Market Report:
Pharmacovigilance And Drug Safety Software Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model